Integral Derivatives’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$183K Sell
11,500
-75,400
-87% -$1.4M ﹤0.01% 623
2017
Q4
$1.81M Sell
86,900
-71,800
-45% -$1.14M 0.04% 321
2017
Q3
$2.27M Sell
158,700
-81,400
-34% -$1.23M 0.04% 280
2017
Q2
$4.15M Buy
240,100
+168,100
+233% +$2.02M 0.09% 142
2017
Q1
$794K Sell
72,000
-117,800
-62% -$1.62M 0.01% 599
2016
Q4
$2.76M Buy
189,800
+29,100
+18% +$534K 0.05% 240
2016
Q3
$3.94M Buy
160,700
+11,400
+8% +$295K 0.08% 142
2016
Q2
$3.01M Buy
149,300
+88,500
+146% +$2.51M 0.07% 158
2016
Q1
$1.6M Buy
60,800
+5,400
+10% +$399K 0.05% 262
2015
Q4
$5.63M Buy
55,400
+34,300
+163% +$3.85M 0.14% 113
2015
Q3
$3.76M Buy
21,100
+14,900
+240% +$3.47M 0.1% 159
2015
Q2
$1.38M Sell
6,200
-7,500
-55% -$1.66M 0.04% 421
2015
Q1
$2.72M Sell
13,700
-2,600
-16% -$461K 0.06% 210
2014
Q4
$2.33M Buy
16,300
+8,000
+96% +$1.08M 0.04% 386
2014
Q3
$1.09M Sell
8,300
-10,500
-56% -$1.25M 0.02% 672
2014
Q2
$2.37M Sell
18,800
-3,300
-15% -$421K 0.04% 359
2014
Q1
$2.91M Buy
22,100
+100
+0.5% +$13.7K 0.06% 305
2013
Q4
$2.58M Buy
+22,000
New +$2.41M 0.04% 401

Other funds holding BHC

Integral Derivatives's BHC Position: Q4 2017 in Review

Integral Derivatives sold out of Bausch Health (BHC) in Q4 2017, closing a stake of 34,053 shares — an estimated $540K sold.

Integral Derivatives first reported a position in BHC in Q2 2014 and held it in 10 quarters. The position peaked at $2.37M in Q4 2015. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2017.

  • Integral Derivatives reported no remaining Bausch Health position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 34,053 Bausch Health shares in Q4 2017, an estimated $540K.
  • Integral Derivatives first reported a position in Bausch Health in Q2 2014 and held it in 10 quarters.
  • Integral Derivatives's Bausch Health position peaked at $2.37M in Q4 2015.
  • 315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.